Although the exact molecular mechanisms are not fully understood, there is strong evidence that fetuin-A plays a critical role in the pathophysiological pathways leading to various metabolic disorders, making it a valuable target for early diagnosis in clinical practice. This evidence concerns the gene AHSG and metabolic disease.